Needham & Company started coverage on Carlsmed shares, which is listed on Nasdaq, with MarketBeat reporting on the stock.
4 reports, 3 independent
Updated Oct 15
Gone quiet
- Reports
- 4
- Developments
- 3
- Repetition
- 25%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Needham & Company started coverage on Carlsmed shares, which is listed on Nasdaq, with MarketBeat reporting on the stock.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Multiple analysts and investors made new moves regarding Carlsmed stock.1 source
Carlsmed presented at a Bank of America virtual event following its Nasdaq listing.1 source
Needham begins coverage of Carlsmed, a Nasdaq-listed stock, with MarketBeat reporting on it.1 source
Keep exploring
The entities involved
-
Needham & Company
American independent investment bank and asset management firm
-
Nasdaq
American fully electronic stock exchange
- Chainlink, Nasdaq, Depository Trust & Clearing Corporation, and New York Stock Exchange are partnering on a tokenization platform for clearing services related to real-world assets and equities.
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.